A Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients in India
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Anti-thrombotic treatment strategies in a 'real-life' observational setting across different sites in India.
研究概览
简要总结
TRACE is a Multicentre Retrospective Study planned to gather follow up data for a period of 1 year in order to understand anti-thrombotic management patterns and outcomes of Acute Coronary Syndrome patients in India.
This retrospective study is designed to provide a rapid and quick analysis of the existing database of ACS patients. So as to ensure quality check in the study, a pilot study will be conducted with around 500 patients at 10 centres across India and based on the meaningful results of the pilot study, full retrospective multi-centric study will be initiated at various selected centres across India. This study will use available registry data from a defined time period of Jan 2007-Dec 2009.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients of the age of 18 years or older and hospitalized for ACS within the previous 3 years.
- •Diagnosis of STEMI, NSTEMI or UA using Standard and Universal Definition of Myocardial Infarction
排除标准
- •UA, STEMI and NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI.
- •UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons
结局指标
主要结局
Anti-thrombotic treatment strategies in a 'real-life' observational setting across different sites in India.
时间窗: Jan 2007-Dec 2009
Anti thrombotic strategies used in ACS patients
时间窗: Jan 2007-Dec 2009
次要结局
- ACS outcomes with respect to: -Revascularization -Angina/ Re-infarction -Cardiogenic shock/Heart failure/Cardiac arrest -Atrial fibrillation/flutter -Ventricular Fibrillation/ Sustained V Tachycardia -Stroke -Mortality -Bleeding(Jan 2007-Dec 2009)
